Literature DB >> 26332578

Tau phosphorylation-associated spine regression does not impair hippocampal-dependent memory in hibernating golden hamsters.

Torsten Bullmann1,2, Gudrun Seeger1, Jens Stieler1, János Hanics3,4, Katja Reimann1, Tanja Petra Kretzschmann1, Isabel Hilbrich1, Max Holzer1, Alán Alpár3,4, Thomas Arendt1.   

Abstract

The microtubule-associated protein tau, in its hyperphosphorylated form, is the major component of paired helical filaments and other aggregates in neurodegenerative disorders commonly referred to as "tauopathies". Recent evidence, however, indicates that mislocalization of hyperphosphorylated tau to subsynaptic sites leads to synaptic impairment and cognitive decline even long before formation of tau aggregates and neurodegeneration occur. A similar, but reversible hyperphosphorylation of tau occurs under physiologically controlled conditions during hibernation. Here, we study the hibernating Golden hamster (Syrian hamster, Mesocricetus auratus). A transient spine reduction was observed in the hippocampus, especially on apical dendrites of hippocampal CA3 pyramidal cells, but not on their basal dendrites. This distribution of structural synaptic regression was correlated to the distribution of phosphorylated tau, which was highly abundant in apical dendrites but hardly detectable in basal dendrites. Surprisingly, hippocampal memory assessed by a labyrinth maze was not affected by hibernation. The present study suggests a role for soluble hyperphosphorylated tau in the process of reversible synaptic regression, which does not lead to memory impairment during hibernation. We hypothesize that tau phosphorylation associated spine regression might mainly affect unstable/dynamic spines while sparing established/stable spines.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Alzheimer's disease; hypometabolism; microtubule associated protein; protein phosphorylation; torpor

Mesh:

Substances:

Year:  2015        PMID: 26332578     DOI: 10.1002/hipo.22522

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  10 in total

Review 1.  The Exceptional Vulnerability of Humans to Alzheimer's Disease.

Authors:  Lary C Walker; Mathias Jucker
Journal:  Trends Mol Med       Date:  2017-05-05       Impact factor: 11.951

2.  Secretagogin marks amygdaloid PKCδ interneurons and modulates NMDA receptor availability.

Authors:  Zsófia Hevesi; Dóra Zelena; Roman A Romanov; János Hanics; Attila Ignácz; Alice Zambon; Daniela D Pollak; Dávid Lendvai; Katalin Schlett; Miklós Palkovits; Tibor Harkany; Tomas G M Hökfelt; Alán Alpár
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-16       Impact factor: 11.205

3.  Glucocorticoid-mediated activation of GSK3β promotes tau phosphorylation and impairs memory in type 2 diabetes.

Authors:  Aditi Dey; Shuai Hao; Marlena Wosiski-Kuhn; Alexis M Stranahan
Journal:  Neurobiol Aging       Date:  2017-05-19       Impact factor: 4.673

4.  Syrian hamster neuroplasticity mechanisms fail as temperature declines to 15 °C, but histaminergic neuromodulation persists.

Authors:  Jock S Hamilton; Sat M Chau; Kevin J Malins; Giancarlo G Ibanez; John M Horowitz; Barbara A Horwitz
Journal:  J Comp Physiol B       Date:  2017-04-09       Impact factor: 2.200

Review 5.  Antipsychotic inductors of brain hypothermia and torpor-like states: perspectives of application.

Authors:  Yury S Tarahovsky; Irina S Fadeeva; Natalia P Komelina; Maxim O Khrenov; Nadezhda M Zakharova
Journal:  Psychopharmacology (Berl)       Date:  2016-12-08       Impact factor: 4.530

Review 6.  The Torpid State: Recent Advances in Metabolic Adaptations and Protective Mechanisms.

Authors:  Sylvain Giroud; Caroline Habold; Roberto F Nespolo; Carlos Mejías; Jérémy Terrien; Samantha M Logan; Robert H Henning; Kenneth B Storey
Journal:  Front Physiol       Date:  2021-01-20       Impact factor: 4.566

7.  Similarities and Differences in the Pattern of Tau Hyperphosphorylation in Physiological and Pathological Conditions: Impacts on the Elaboration of Therapies to Prevent Tau Pathology.

Authors:  Antoine Duquette; Camille Pernègre; Ariane Veilleux Carpentier; Nicole Leclerc
Journal:  Front Neurol       Date:  2021-01-07       Impact factor: 4.003

8.  SPG302 Reverses Synaptic and Cognitive Deficits Without Altering Amyloid or Tau Pathology in a Transgenic Model of Alzheimer's Disease.

Authors:  Peter W Vanderklish; Vincent F Simmon; David Baglietto-Vargas; Frank M LaFerla; Laura Trujillo-Estrada; Marie Minh Thu Nguyen; Run Rong Kuang; Caroline Nguyen; Eric Huynh; Celia da Cunha; Dominic Ibarra Javonillo; Stefania Forner; Alessandra C Martini; Stella T Sarraf
Journal:  Neurotherapeutics       Date:  2021-11-04       Impact factor: 7.620

9.  Effect of Phosphorylated Tau on Cortical Pyramidal Neuron Morphology during Hibernation.

Authors:  Mamen Regalado-Reyes; Ruth Benavides-Piccione; Isabel Fernaud-Espinosa; Javier DeFelipe; Gonzalo León-Espinosa
Journal:  Cereb Cortex Commun       Date:  2020-05-21

10.  Torpor enhances synaptic strength and restores memory performance in a mouse model of Alzheimer's disease.

Authors:  Christina F de Veij Mestdagh; Jaap A Timmerman; Frank Koopmans; Iryna Paliukhovich; Suzanne S M Miedema; Maaike Goris; Rolinka J van der Loo; Guido Krenning; Ka Wan Li; Huibert D Mansvelder; August B Smit; Robert H Henning; Ronald E van Kesteren
Journal:  Sci Rep       Date:  2021-07-29       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.